Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adrenoreceptors and renal function.

J D Wallin

    Journal of Clinical Hypertension
    |June 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Labetalol, an antihypertensive drug blocking alpha and beta adrenoreceptors, generally shows no significant negative impact on renal function. Studies indicate stable glomerular filtration rate and renal plasma flow during labetalol therapy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Antihypertensive effect of the combination of fosinopril and HCTZ is resistant to interference by nonsteroidal antiinflammatory drugs.

    American journal of hypertension·1999
    Same author

    End-stage renal disease in specific ethnic and racial groups: risk factors and benefits of antihypertensive therapy.

    Archives of internal medicine·1998
    Same author

    Parenteral hydralazine revisited.

    The Journal of emergency medicine·1998
    Same author

    Comparative effects of nabumetone, sulindac, and ibuprofen on renal function.

    The Journal of rheumatology·1997
    Same author

    Calcium antagonists and the kidney.

    New horizons (Baltimore, Md.)·1996
    Same author

    Labetalol and other agents that block both alpha- and beta-adrenergic receptors.

    Cleveland Clinic journal of medicine·1994

    Area of Science:

    • Pharmacology
    • Nephrology
    • Cardiovascular Medicine

    Background:

    • Alpha- and beta-adrenoreceptor blockade influence renal function.
    • Labetalol is an antihypertensive agent with dual alpha- and beta-adrenoreceptor blocking properties.

    Purpose of the Study:

    • To analyze the effects of labetalol on various parameters of renal function.
    • To assess labetalol's impact on patients with normal and impaired renal function.

    Main Methods:

    • Review of published studies on labetalol's renal effects.
    • Detailed analysis of renal function in 17 patients treated with labetalol.
    • Measurement of glomerular filtration rate, renal plasma flow, and other renal parameters.

    Main Results:

    Related Experiment Videos

    • No consistent changes observed in glomerular filtration rate, renal plasma flow, filtration fraction, maximal concentrating ability, or free-water clearance.
    • Renal vascular resistance tended to decrease in patients with normal renal function.
    • Renal vascular resistance showed inconsistent changes in patients with impaired renal function.

    Conclusions:

    • Labetalol demonstrates minimal negative impact on overall renal function.
    • The drug appears safe for patients with varying degrees of renal impairment.
    • Further investigation into renal vascular resistance changes may be warranted.